SOBR Safe, Inc. SOBR
On September 19, 2011, we, as Imagine Media, Ltd., a Delaware corporation, acquired approximately 52% of the outstanding shares of TransBiotec, Inc. ("TBT"), a California corporation, from TBT's directors in exchange for 124,439 shares of our common stock. In January 2012, our Board of Directors (the "Board") amended our Certificate of Incorporation, changing our name from Imagine Media, Ltd. to TransBiotec, Inc., and we acquired approximately 45% of the remaining outstanding shares of TBT in exchange for 109,979 shares of our common stock. With the acquisitions in September 2011 and January 2012 of TBT common stock, we own approximately 99% of the outstanding shares of TBT. As a result of the acquisitions, TBT's business is our business, and, unless otherwise indicated, any references to "we" or "us" include the business and operations of TBT.
Valuation FY2026 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $437.4K | $212.7K | $157.3K | $35.3K | $0 | $0 | $0 | — | — |
| Cost of revenue | — | $201.9K | $193.6K | $94.9K | $19.3K | $0 | — | — | — | — |
| Gross profit | — | $235.5K | $19.2K | $62.4K | $16.0K | $0 | — | — | — | — |
| R&D | — | $329.7K | $747.5K | $1.0M | $1.4M | $1.2M | $633.0K | $12.8K | $8.9K | — |
| SG&A | — | $8.1M | $6.2M | $6.4M | $6.0M | $3.9M | $2.0M | $232.2K | $299.0K | $313.1K |
| Total operating expenses | — | $9.4M | $7.7M | $9.7M | $10.4M | $5.6M | $28.3M | $787.3K | $299.0K | $313.1K |
| Operating income | — | -$9.2M | -$7.7M | -$9.6M | -$10.4M | -$5.6M | -$28.3M | -$787.3K | -$299.0K | -$313.1K |
| Interest expense | — | $21.8K | $457.7K | $804.3K | $3.5M | $1.4M | $141.5K | $457.5K | $263.1K | $21.5K |
| Pre-tax income | — | -$9.0M | -$8.6M | -$10.2M | -$12.4M | -$7.9M | -$30.0M | -$1.3M | -$562.1K | -$642.3K |
| Income tax | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — |
| Net income | — | -$9.0M | -$8.6M | -$10.2M | -$12.4M | -$7.9M | -$30.0M | -$1.3M | -$559.0K | -$642.3K |
| EPS, diluted | — | -6.12 | -172.19 | -619.15 | — | -0.30 | -1.95 | -0.23 | -0.01 | -0.01 |
| Shares, diluted (wtd. avg.) | — | 1.5M | 61,342 | 16,498 | — | 26.0M | 15.4M | — | — | — |
Balance sheet
| Fiscal year | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | $4.8M | $8.4M | $2.8M | $8.6M | $882.3K | $232.8K | $681.8K | $89 | $142 |
| Receivables | — | $35.9K | $24.5K | $25.3K | $30.3K | $354.5K | $0 | — | — | — |
| Inventory | — | $146.5K | $224.9K | $342.8K | $215.5K | $39.5K | $0 | — | — | — |
| Total current assets | — | $5.2M | $8.9M | $3.4M | $9.0M | $934.3K | $348.1K | $690.8K | $13.1K | $3.1K |
| Property, plant and equipment | — | $34.4K | $0 | — | — | $0 | $0 | — | — | — |
| Other intangibles | — | $1.2M | $2.1M | $2.5M | $2.9M | $3.2M | $3.6M | $0 | — | — |
| Total assets | — | $6.6M | $11.2M | $6.1M | $11.9M | $4.2M | $4.0M | $690.8K | $13.1K | $3.1K |
| Accounts payable | — | $484.7K | $422.6K | $525.7K | $143.0K | $270.1K | $101.3K | $213.9K | $191.7K | $270.9K |
| Short-term debt | — | — | $127.6K | $64.3K | — | — | — | — | — | — |
| Total current liabilities | — | $1.7M | $1.3M | $1.5M | $2.8M | $4.0M | $922.1K | $4.3M | $3.4M | $3.0M |
| Long-term debt | — | — | — | $2.3M | $0 | — | — | — | — | — |
| Total liabilities | — | $1.7M | $1.4M | $4.2M | $2.8M | $4.7M | $947.1K | $4.3M | $3.4M | $3.0M |
| Retained earnings | — | -$107.3M | -$98.3M | -$87.8M | -$78.3M | -$57.5M | -$49.6M | -$19.5M | -$18.3M | -$17.7M |
| Total equity | — | $5.0M | $9.9M | $2.0M | $9.1M | -$483.6K | $3.0M | -$3.6M | -$3.4M | -$3.0M |
Cash flow
| Fiscal year | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | -$7.0M | -$6.5M | -$5.9M | -$6.2M | -$3.7M | -$2.2M | -$544.0K | -$61.4K | -$162.6K |
| Depreciation and amortisation | — | $3.8K | $0 | — | — | $385.5K | $232.2K | $0 | — | — |
| Stock-based compensation | — | $485.4K | $729.7K | $2.2M | $3.0M | $473.7K | $273.4K | $44.1K | $20.8K | $6.3K |
| Capital expenditure | — | $38.2K | $0 | — | — | — | — | — | — | — |
| Investing cash flow | — | -$38.2K | $0 | — | — | — | — | — | — | — |
| Financing cash flow | — | $3.4M | $12.1M | $139.2K | $13.9M | $4.3M | $1.7M | $1.2M | $61.3K | $148.4K |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001477932-26-002754.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0 | $0 | $0 | $35.3K | $157.3K | $212.7K | $437.4K | — |
| Gross profit | — | — | — | — | $0 | $16.0K | $62.4K | $19.2K | $235.5K | — |
| Net income | -$642.3K | -$559.0K | -$1.3M | -$30.0M | -$7.9M | -$12.4M | -$10.2M | -$8.6M | -$9.0M | — |
Recent filings and events
- Delisting notice The exchange has told the company it no longer meets the rules for staying listed - usually price, market cap, or filings that are late. Item 3.01
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Restructuring or exit costs A restructuring: layoffs, a plant closure, a business being wound down. Item 2.05
- Delisting notice Item 3.01
- Restructuring or exit costs Item 2.05
- Material agreement signed Item 1.01
- Acquisition or disposal completed A purchase or sale of a significant business or asset has closed. Item 2.01
- Change of control Control of the company has changed hands. Item 5.01
- Officer or director change Item 5.02
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.